News

Castle Connolly Releases Castle Connolly Top Hispanic & Latino Doctors 2023

For the first time, list recognizes 234 leading Hispanic and Latino doctors in the nationNEW YORK, NY / ACCESSWIRE /…

6 months ago

Rancho BioSciences Collaborates to Standardize UK Biobank Clinical Data for Improved Genetic Analysis

RANCHO SANTA FE, CA / ACCESSWIRE / September 26, 2023 / A leading global pharmaceutical company has partnered with Rancho…

6 months ago

Napo Pharmaceuticals Supports Groundbreaking Study on Quality of Life for Cancer Patients and Survivors

SAN FRANCISCO, CA / ACCESSWIRE / September 26, 2023 / In an effort to shed light on the diverse and…

6 months ago

Holon Solutions and HealtHIE Nevada Team Up to Transform Human-Centric Care Delivery in Nevada

The collaboration will break down data silos in healthcare to improve patient outcomes and provide relief to healthcare teams – so…

6 months ago

Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting

Deconvolution Analysis Shows 60% Increase in GH Secretion, Comparable to Established Values in Normal Children Analysis Shows Annualized Height Velocity…

6 months ago

IR-MED to Conduct Usability Study with Methodist Healthcare of San Antonio for its PressureSafe Device Which is Slated for U.S. Launch in H1 2024

IR-Med, Inc. Figure 1PressureSafe, a skin color agnostic decision support device, for the early detection of pressure injuriesStudy to address…

6 months ago

As Applications for Opioid Use Disorder (OUD) Treatment Surge, Bicycle Health Makes Population-level Applicant Data Available On New Data Hub

The data hub provides policymakers and advocates with insights into the demographics and history of people seeking treatment to inform…

6 months ago

Signati™ Medical Files IDE Study with FDA

Providence, RI, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Signati™ Medical has officially filed their IDE study with the FDA. An…

6 months ago

Lexicon to Present Study Results Relating to Sotagliflozin and LX9211 at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)

INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure LX9211 is an investigational, non-opioid treatment for diabetic peripheral…

6 months ago

XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke

AUSTIN, Texas, Sept. 26, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) Announces that Hutrukin is being developed by XBiotech as…

6 months ago